JP2024546179A5 - - Google Patents
Info
- Publication number
- JP2024546179A5 JP2024546179A5 JP2024538282A JP2024538282A JP2024546179A5 JP 2024546179 A5 JP2024546179 A5 JP 2024546179A5 JP 2024538282 A JP2024538282 A JP 2024538282A JP 2024538282 A JP2024538282 A JP 2024538282A JP 2024546179 A5 JP2024546179 A5 JP 2024546179A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- liquid pharmaceutical
- pharmaceutical preparation
- pharmaceutical formulation
- oleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217653.1 | 2021-12-23 | ||
| EP21217653 | 2021-12-23 | ||
| PCT/GB2022/053380 WO2023118896A1 (en) | 2021-12-23 | 2022-12-23 | Novel antiviral compositions comprising oleic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546179A JP2024546179A (ja) | 2024-12-17 |
| JP2024546179A5 true JP2024546179A5 (https=) | 2026-01-07 |
Family
ID=79165052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538282A Pending JP2024546179A (ja) | 2021-12-23 | 2022-12-23 | 新規な抗ウイルス性のオレイン酸含有組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250152545A1 (https=) |
| EP (1) | EP4452220A1 (https=) |
| JP (1) | JP2024546179A (https=) |
| CN (1) | CN118488831A (https=) |
| AU (1) | AU2022422584A1 (https=) |
| CA (1) | CA3238128A1 (https=) |
| WO (1) | WO2023118896A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260032554A (ko) * | 2023-06-29 | 2026-03-09 | 리그이뮨 아이엔씨. | 신규한 제형 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2577321A (en) | 1949-10-29 | 1951-12-04 | Joseph B Filger | Nose drop dispenser |
| AU527371B2 (en) | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
| US5231184A (en) | 1987-11-23 | 1993-07-27 | Janssen Pharmaceutica N.V. | Pridazinamine derivatives |
| US5539122A (en) | 1989-05-23 | 1996-07-23 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| AP249A (en) | 1990-04-24 | 1993-03-17 | Biota Scient Management Pty Ltd | Anti-viral compounds. |
| US5290539A (en) | 1990-12-21 | 1994-03-01 | Minnesota Mining And Manufacturing Company | Device for delivering an aerosol |
| US6000580A (en) | 1992-06-03 | 1999-12-14 | Astra Aktielbolag | Device for dispensing preservative-free nasal sprays and similar preparations |
| CA2166970C (en) | 1993-07-15 | 2000-12-19 | Oh-Seung Kwon | Seals for use in an aerosol delivery device |
| HU219899B (hu) | 1995-04-14 | 2001-09-28 | Glaxo Wellcome Inc. | Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US5763483A (en) | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| ATE294185T1 (de) | 2000-02-16 | 2005-05-15 | Toyama Chemical Co Ltd | Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediäre zur herstellung der derivate |
| AU2002238801A1 (en) | 2001-03-20 | 2002-10-03 | Trudell Medical International | Nebulizer apparatus and method |
| WO2003047516A2 (en) | 2001-11-30 | 2003-06-12 | Synta Pharmaceuticals Corporation | Pyrimidine compounds |
| WO2016118709A1 (en) * | 2015-01-23 | 2016-07-28 | Lam Therapeutics, Inc. | Anti-viral compositions containing pikfyve inhibitors and use thereof |
| US20180271873A1 (en) | 2015-04-01 | 2018-09-27 | The California Institute For Biomedical Research | Methods for treating viral infections |
| WO2017184668A1 (en) | 2016-04-20 | 2017-10-26 | Gilead Sciences, Inc. | Methods for treating flaviviridae virus infections |
| PT3706762T (pt) | 2017-12-07 | 2024-12-05 | Univ Emory | N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos |
| CA3170133A1 (en) * | 2020-02-07 | 2021-08-12 | AI Therapeutics, Inc. | Anti-viral compositions and methods of use |
| JP2023513227A (ja) * | 2020-02-14 | 2023-03-30 | エバイブ バイオテクノロジー （シャンハイ） リミテッド | Ｉｌ－２２二量体を用いたウイルス誘発性臓器損傷又は不全の予防又は治療方法 |
| CN111265499B (zh) * | 2020-02-17 | 2022-11-15 | 江苏艾立康医药科技有限公司 | 一种洛匹那韦吸入气雾剂及其制备方法 |
| WO2021211738A1 (en) | 2020-04-15 | 2021-10-21 | Sanford Burnham Prebys Medical Discovery Institute | Methods and compositions for antiviral treatment |
| US20230218644A1 (en) * | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
| JP2023526327A (ja) * | 2020-05-15 | 2023-06-21 | ヒーリオン バイオ，インコーポレイテッド | 薬物の有効性を高めるための組成物及び方法 |
| US20210379090A1 (en) * | 2020-06-09 | 2021-12-09 | Abon Pharmaceuticals, Llc | Remdesivir oral delivery system |
| CN112206225A (zh) * | 2020-07-16 | 2021-01-12 | 郑鉴忠 | 君臣佐使配伍的抗新冠病毒西药生产方法 |
| CN112891327A (zh) * | 2021-03-03 | 2021-06-04 | 陈西敬 | 瑞德西韦雾化吸入用液体制剂及其制备方法 |
| EP4337179A4 (en) * | 2021-05-10 | 2025-04-30 | Topelia Aust Limited (ACN 652 771 670) | METHODS OF TREATING, IMPROVING, OR PREVENTING INFECTIONS USING COMBINATION DRUG AND VACCINATION THERAPY |
-
2022
- 2022-12-23 EP EP22839442.5A patent/EP4452220A1/en active Pending
- 2022-12-23 WO PCT/GB2022/053380 patent/WO2023118896A1/en not_active Ceased
- 2022-12-23 JP JP2024538282A patent/JP2024546179A/ja active Pending
- 2022-12-23 CA CA3238128A patent/CA3238128A1/en active Pending
- 2022-12-23 CN CN202280083493.2A patent/CN118488831A/zh active Pending
- 2022-12-23 US US18/722,843 patent/US20250152545A1/en active Pending
- 2022-12-23 AU AU2022422584A patent/AU2022422584A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5863641B2 (ja) | 濃縮肥満細胞安定化用薬学的調合物 | |
| FI4279070T3 (fi) | Koostumus sisältäen 5-metoksi-N,N-dimetyylitryotamini-bentsoaattisuolaa | |
| TWI758617B (zh) | 包含格隆銨鹽及茚達特羅鹽的氣霧劑藥物組合物、其製備方法與用途 | |
| RU2019100425A (ru) | Новая доза и препаративная форма | |
| JP2002104963A (ja) | 痛みの治療または予防のための吸入可能なエーロゾル薬剤 | |
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| JP2015508780A5 (https=) | ||
| EA022840B1 (ru) | Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа | |
| CA3180854A1 (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
| JP2014513091A5 (https=) | ||
| JP2024515446A5 (https=) | ||
| WO2015027848A1 (zh) | 含有帕拉米韦和/或其衍生物制剂的给药方法 | |
| EP3892275A1 (en) | Aerosolization of hcq or its metabolites for the treatment of lung infections | |
| JP2024546179A5 (https=) | ||
| WO2021150489A1 (en) | Inhalable formulation of a solution containing glycopyrrolate and olodaterol hydrochloride | |
| RU2010120806A (ru) | Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид | |
| CN119700755A (zh) | 化合物在制备预防和/或治疗高原病的药物中的应用 | |
| KR20230005937A (ko) | 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법 | |
| WO2010009288A1 (en) | Compositions and uses of antiviral active pharmaceutical agents | |
| US20200405700A1 (en) | Inhalable formulation of a solution containing formoterol fumarate and aclidinium bromide | |
| WO2022063320A1 (zh) | 一种抑制呼吸道病毒的组合物及呼吸道病毒防治方法 | |
| EP4005565A1 (en) | Novel uses of adamantane derivatives | |
| WO2015027847A2 (zh) | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 | |
| US20240415944A1 (en) | Aqueous aprotinin-containing antiviral pharmaceutical composition | |
| US20210205223A1 (en) | Propellant-free formulation for inhalation |